invIOs (private company)
See something wrong or missing? Let us know
Offices:Vienna
Business model:B2B
invIOs is a biotech startup in Austria spun off Apeiron in 2022 and focused on discovery and development of next-generation cancer therapies.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 9.1M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to invIOs
Name | Criteria | |
---|---|---|
![]() |
Biograil
60%
|
|
![]() |
Cebiotex
60%
|
|
![]() |
Cell-Easy
60%
|
|
![]() |
Curida
60%
|
|
![]() |
Gradientech
60%
|
|
![]() |
Octarine Bio
60%
|
|
![]() |
Sarcura
60%
|
|
![]() |
ViveBiotech
60%
|
|
![]() |
PEP-Therapy
60%
|
|
![]() |
Harg
60%
|
|